Cutaneous T-Cell Lymphoma Clinical Trials

A listing of Cutaneous T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

The body has different ways of fighting infection and disease. No single way is perfect for fighting cancer. This research study combines two different ways of fighting disease: antibodies and T cells. Antibodies are proteins that protect the body from disease caused by bacteria or toxic substances. Antibodies work by …

primary cutaneous anaplastic large cell lymphoma
anthracycline
b-cell lymphoma
large cell lymphoma
lymphoma
  • 323 views
  • 25 May, 2022
  • 1 location
Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

In this pilot study, pembrolizumab will be administered via DoseConnect in patient with relapsed or refractory cutaneous T-cell lymphoma to assess through pharmacodynamic assessment in the tumor

brentuximab
lymphoma
mycosis
systemic therapy
t-cell lymphoma
  • 0 views
  • 23 Jul, 2022
  • 1 location
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

This is a Phase I Trial to assess the feasibility of Romidepsin combined with Brentuximab Vedotin for patients requiring Systemic Therapy for Cutaneous T-cell Lymphoma.

mycosis
cutaneous t-cell lymphoma
neutrophil count
romidepsin
flow cytometry
  • 2 views
  • 23 Jul, 2022
  • 1 location
Mogamulizumab Q4week Dosing in Participants With R/R CTCL

/refractory MF and SS subtypes of CTCL. The study is composed of a 28-day Screening Period during which participants are screened for entry into this study, followed by a treatment period of up to 2 years

  • 0 views
  • 19 Apr, 2022
  • 5 locations
REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (REACH)

Adult patients with early stage MF-CTCL (stage IA-IB) will be eligible for this study. A total of 100 early stage MF-CTCL patients diagnosed in the past year will be enrolled. Treatment

  • 0 views
  • 01 May, 2022
  • 1 location
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

/refractory cutaneous T-cell lymphoma.

neutrophil count
lymphoma
treatment regimen
cutaneous t-cell lymphoma
  • 0 views
  • 28 Feb, 2022
  • 1 location
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

The researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene

cancer
mycosis
cutaneous t-cell lymphoma
topical steroids
lymphoma
  • 0 views
  • 11 Jul, 2022
  • 1 location
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

The purpose of this study is to determine the efficacy of the combination of LD-TSEBT and mogamulizumab in patients with MF and SS. And to evaluate the secondary measures of clinical benefit of the combination therapy and to evaluate the safety and tolerability of the combination in patients with MF …

cancer therapy
gilbert's syndrome
malignant disease
cutaneous t-cell lymphoma
neutrophil count
  • 19 views
  • 25 Apr, 2022
  • 1 location
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

effectiveness of several approved cancer drugs against cutaneous T cell lymphoma and peripheral T cell lymphoma

cutaneous t-cell lymphoma
neutrophil count
lymphoma
systemic therapy
experimental drug
  • 0 views
  • 29 Jul, 2022
  • 1 location
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

The purpose of this study is to test any good and bad effects of the study drug called brentuximab vedotin at a lower dose than is FDA-approved.

cancer
cancer therapy
mycosis
immunomodulator
adrenal insufficiency
  • 115 views
  • 05 Mar, 2022
  • 8 locations